Generic Industry Looking For Expanded Inspections As US FDA Rehires Staff

 
• By Grace Moser
  
AAM said FDA inspections have not returned to pre-COVID-19 pandemic levels. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from United States